{"id":"https://openalex.org/W2086475971","doi":"https://doi.org/10.1016/s0014-5793(99)00084-8","title":"Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding","display_name":"Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding","alternate_titles":[],"publication_year":1999,"publication_date":"1999-02-19","ids":{"openalex":"https://openalex.org/W2086475971","doi":"https://doi.org/10.1016/s0014-5793(99)00084-8","mag":"2086475971","pmid":"https://pubmed.ncbi.nlm.nih.gov/10069366"},"language":"en","primary_location":{"id":"doi:10.1016/s0014-5793(99)00084-8","doi":"https://doi.org/10.1016/s0014-5793(99)00084-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0014-5793(99)00084-8","pdf_url":null,"source":{"id":"https://openalex.org/S104830714","display_name":"FEBS Letters","issn_l":"0014-5793","issn":["0014-5793","1873-3468"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FEBS Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2086475971"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103526120","display_name":"Hideko Yamamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088202","display_name":"Tokyo Institute of Psychiatry","ror":"https://ror.org/007c88108","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210088202","https://openalex.org/I4210098918"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hideko Yamamoto","raw_affiliation_strings":["Department of Psychopharmacology, Tokyo Institute of Psychiatry, Japan","Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychopharmacology, Tokyo Institute of Psychiatry, Japan","institution_ids":["https://openalex.org/I4210088202"]},{"raw_affiliation_string":"Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan","institution_ids":["https://openalex.org/I4210088202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114001412","display_name":"Reiko Miura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088202","display_name":"Tokyo Institute of Psychiatry","ror":"https://ror.org/007c88108","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210088202","https://openalex.org/I4210098918"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Reiko Miura","raw_affiliation_strings":["Department of Neurochemistry, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurochemistry, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan","institution_ids":["https://openalex.org/I4210088202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111746326","display_name":"Toshifumi Yamamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088202","display_name":"Tokyo Institute of Psychiatry","ror":"https://ror.org/007c88108","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210088202","https://openalex.org/I4210098918"]},{"id":"https://openalex.org/I89630735","display_name":"Yokohama City University","ror":"https://ror.org/0135d1r83","country_code":"JP","type":"education","lineage":["https://openalex.org/I89630735"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toshifumi Yamamoto","raw_affiliation_strings":["Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan","Molecular Recognition, Yokohama City University, Yokohama 236-0027, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan","institution_ids":["https://openalex.org/I4210088202"]},{"raw_affiliation_string":"Molecular Recognition, Yokohama City University, Yokohama 236-0027, Japan","institution_ids":["https://openalex.org/I89630735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050118753","display_name":"Keiko Shinohara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088202","display_name":"Tokyo Institute of Psychiatry","ror":"https://ror.org/007c88108","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210088202","https://openalex.org/I4210098918"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keiko Shinohara","raw_affiliation_strings":["Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan","institution_ids":["https://openalex.org/I4210088202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023649927","display_name":"Masayuki Watanabe","orcid":"https://orcid.org/0000-0003-4198-3085","observed_orcids":["https://orcid.org/0000-0003-4198-3085"]},"institutions":[{"id":"https://openalex.org/I4210088202","display_name":"Tokyo Institute of Psychiatry","ror":"https://ror.org/007c88108","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210088202","https://openalex.org/I4210098918"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masayuki Watanabe","raw_affiliation_strings":["Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychopharmacology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan","institution_ids":["https://openalex.org/I4210088202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110113221","display_name":"Shigeru Okuyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shigeru Okuyama","raw_affiliation_strings":["The 1st Laboratory, Medicinal Research Laboratory, Taisho Pharmaceutical, Saitama 330-8530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The 1st Laboratory, Medicinal Research Laboratory, Taisho Pharmaceutical, Saitama 330-8530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113554239","display_name":"Atsuro Nakazato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Atsuro Nakazato","raw_affiliation_strings":["The 1st Laboratory, Medicinal Research Laboratory, Taisho Pharmaceutical, Saitama 330-8530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The 1st Laboratory, Medicinal Research Laboratory, Taisho Pharmaceutical, Saitama 330-8530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108583353","display_name":"Toshihide Nukada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088202","display_name":"Tokyo Institute of Psychiatry","ror":"https://ror.org/007c88108","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210088202","https://openalex.org/I4210098918"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Toshihide Nukada","raw_affiliation_strings":["Department of Neurochemistry, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurochemistry, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan","institution_ids":["https://openalex.org/I4210088202"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5108583353"],"corresponding_institution_ids":["https://openalex.org/I4210088202"],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":null,"fwci":1.8356,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.817506,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"445","issue":"1","first_page":"19","last_page":"22"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sigma-1-receptor","display_name":"sigma-1 receptor","score":0.8690000176429749},{"id":"https://openalex.org/keywords/transmembrane-domain","display_name":"transmembrane domain","score":0.9779999852180481},{"id":"https://openalex.org/keywords/ligand-binding","display_name":"ligand binding","score":0.9259999990463257},{"id":"https://openalex.org/keywords/amino-acid-substitutions","display_name":"amino acid substitutions","score":0.7509999871253967},{"id":"https://openalex.org/keywords/pentazocine","display_name":"pentazocine","score":0.9390000104904175},{"id":"https://openalex.org/keywords/ne-100","display_name":"NE-100","score":0.9950000047683716},{"id":"https://openalex.org/keywords/xenopus-oocyte-expression-system","display_name":"Xenopus oocyte expression","score":0.7200000286102295},{"id":"https://openalex.org/keywords/receptor-expression-levels","display_name":"receptor expression levels","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C118892022","wikidata":"https://www.wikidata.org/wiki/Q7834587","display_name":"Transmembrane domain","level":3,"score":0.669183075428009},{"id":"https://openalex.org/C2777052854","wikidata":"https://www.wikidata.org/wiki/Q7512419","display_name":"Sigma receptor","level":3,"score":0.6137523651123047},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5970938205718994},{"id":"https://openalex.org/C2778049214","wikidata":"https://www.wikidata.org/wiki/Q7512234","display_name":"Sigma","level":2,"score":0.5693831443786621},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.5486853122711182},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.5369237661361694},{"id":"https://openalex.org/C24530287","wikidata":"https://www.wikidata.org/wiki/Q424204","display_name":"Transmembrane protein","level":3,"score":0.5358186364173889},{"id":"https://openalex.org/C103133801","wikidata":"https://www.wikidata.org/wiki/Q408572","display_name":"Sigma-1 receptor","level":4,"score":0.4770350158214569},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4665657579898834},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3789718449115753},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3353980779647827},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.07780203223228455},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.05958941578865051},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000097605","descriptor_name":"Sigma-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000840","descriptor_name":"Anisoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002462","descriptor_name":"Cell Membrane","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009865","descriptor_name":"Oocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010423","descriptor_name":"Pentazocine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014981","descriptor_name":"Xenopus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0014-5793(99)00084-8","doi":"https://doi.org/10.1016/s0014-5793(99)00084-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0014-5793(99)00084-8","pdf_url":null,"source":{"id":"https://openalex.org/S104830714","display_name":"FEBS Letters","issn_l":"0014-5793","issn":["0014-5793","1873-3468"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FEBS Letters","raw_type":"journal-article"},{"id":"pmid:10069366","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10069366","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FEBS letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1429166051","https://openalex.org/W1581548318","https://openalex.org/W1886668162","https://openalex.org/W1900414416","https://openalex.org/W1993196185","https://openalex.org/W1994224293","https://openalex.org/W1996137477","https://openalex.org/W2002775774","https://openalex.org/W2006283790","https://openalex.org/W2025528306","https://openalex.org/W2026692772","https://openalex.org/W2038190045","https://openalex.org/W2043813981","https://openalex.org/W2045311068","https://openalex.org/W2050563394","https://openalex.org/W2054526272","https://openalex.org/W2054597500","https://openalex.org/W2056086999","https://openalex.org/W2064705585","https://openalex.org/W2066357614","https://openalex.org/W2073117554","https://openalex.org/W2078121779","https://openalex.org/W2092874909","https://openalex.org/W2101108802","https://openalex.org/W2127749802","https://openalex.org/W2130518310","https://openalex.org/W2342367813"],"related_works":["https://openalex.org/W2026638336","https://openalex.org/W2403110410","https://openalex.org/W2050666972","https://openalex.org/W2047511397","https://openalex.org/W2025169180","https://openalex.org/W2896765768","https://openalex.org/W4389022285","https://openalex.org/W2019726119","https://openalex.org/W4220787842","https://openalex.org/W2018644937"],"abstract_inverted_index":{"The":[0],"type":[1,48,84],"1":[2,49,60,85],"sigma":[3,50,61,86],"receptor":[4,51,62,87],"expressed":[5],"in":[6,25,36,92],"Xenopus":[7],"oocytes":[8],"showed":[9],"binding":[10,67,94],"abilities":[11],"for":[12],"the":[13,37,43,47,72,79,83],"sigma-1":[14],"ligands,":[15],"[3H](+)pentazocine":[16],"and":[17,34],"[3H]NE-100,":[18],"with":[19],"similar":[20],"kinetic":[21],"properties":[22],"as":[23,52],"observed":[24],"native":[26],"tissue":[27],"membranes.":[28],"Amino":[29],"acid":[30],"substitutions":[31],"(Ser99Ala,":[32],"Tyr103Phe":[33],"di-Leu105,106di-Ala)":[35],"transmembrane":[38,80],"domain":[39,81],"did":[40],"not":[41],"alter":[42],"expression":[44],"levels":[45],"of":[46,82,95],"determined":[53],"by":[54,71],"immunoblot":[55],"analysis":[56],"using":[57],"an":[58],"anti-type":[59],"antiserum.":[63],"By":[64],"contrast,":[65],"ligand":[66,93],"was":[68],"significantly":[69],"suppressed":[70],"substitutions.":[73],"These":[74],"findings":[75],"provide":[76],"evidence":[77],"that":[78],"plays":[88],"a":[89],"critical":[90],"role":[91],"this":[96],"receptor.":[97]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2086475971","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
